New Equipment for TB vaccine development - GNT900485 (Old ID 24799)
Role
Principal Investigator
Description
Tuberculosis is a major global public health problem and continues to cause significant morbidity and mortality due to the low efficiency of the only licensed anti-tuberculosis vaccine, BCG. This equipment will facility investigations into novel mechanisms for improved TB vaccines. Tissue dissociation is an integral part of Flow Cytometry and is used on a daily basis in my lab. The gentleMACS™ Octo Dissociator with Heaters is a benchtop instrument capable of fully automated and standardised tissue dissociation or homogenisation of up to eight samples. The instrument allows the user to create user-defined programs for almost any biological material. Using a Gentle MACS Dissociator enhances cell viability, cell yield and significantly decreases the time needed to process organs.
Date
01 Jan 2017 - 31 Dec 2018
Project Type
GRANT
Keywords
mycobaterium tuberculosis (mycobacteria);Microbiome;BCG (mycobacteria);Vaccine Development;Immunology;infectious disease
Funding Body
National Health and Medical Research Council (NHMRC)
Amount
26200
Project Team
N/A